drugset / Trial / NCT01136876

Kidney Damage in Patients With Moderate Fall in eGFR

NCT01136876

Phase 4 Completed 57 enrolled Bracco Diagnostics, Inc
RandomizedParallel-groupTriple-blindDiagnostic

Summary

To compare Iopamidol injection 370 and Iodixanol 320 in evaluating Neutrophil Gelatinase-Associated Lipocalin (NGAL) in patients with moderate fall in eGFR

Timeline

Start
2010-11
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iodixanol Diagnostic / imaging agent
Comparator Iopamidol Diagnostic / imaging agent

Indications